Dr. Gulick's research interests include designing, conducting and analyzing clinical trials to test new agents and refine therapy strategies for HIV and COVID-19 treatment and prevention. He currently serves as Principal Investigator of the Weill Cornell -- New Jersey Medical School Clinical Trials Unit of the AIDS Clinical Trials Group (ACTG) and the HIV Prevention Trials Network (HPTN), sponsored by the National Institutes of Health.